(Q37369561)

20 August 2017

Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments (English)

1 reference

20 August 2017

0 references

3

John R Mascola

1 reference

20 August 2017

5

Dan H Barouch

1 reference

20 August 2017

1

Michael G Hudgens

1 reference

20 August 2017

6

Steven G Self

1 reference

20 August 2017

Peter B Gilbert

2

1 reference

20 August 2017

Chih-Da Wu

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Journal of Infectious Diseases

20 August 2017

1 reference

20 August 2017

200

1 reference

20 August 2017

4

1 reference

20 August 2017

609-613

1 reference

Assessing vaccine effects in repeated low-dose challenge experiments.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

The use of nonhuman primate models in HIV vaccine development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754821

The large sample distribution of the weighted log rank statistic under general local alternatives

2 September 2018

1 reference

12 December 2020

HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges

1 reference

12 December 2020

A strategy for accelerating the development of preventive AIDS vaccines

1 reference

12 December 2020

HIV vaccine research: the way forward

1 reference

12 December 2020

Identifiers

DOI

10.1086/600891

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19591571

1 reference